Pactamycin resistance mutations in functional sites of 16 S rRNA
Abstract
Mutants of an archaeon Halobacterium halobium, resistant to the universal inhibitor of translation, pactamycin, were isolated. Pactamycin resistance correlated with the presence of mutations in the 16 S rRNA gene of H. halobium single rRNA operon. Three types of mutations were found in pactamycin resistant cells, A694G, C795U and C796U (Escherichia coli 16 S rRNA numeration) located distantly in rRNA primary structure but probably neighboring each other in the three-dimensional structure. Pactamycin resistance mutations either overlapped (C795U) or were located in the immediate vicinity of nucleotides protected by the drug in E. coli and H. halobium 16 S rRNA indicating that corresponding rRNA sites might be directly involved in pactamycin binding. Ribosomal functions were not affected significantly either by mutation of C795 (one of the positions protected by the P-site-bound tRNA), or by mutations of A694 and C796 (which neighbor nucleotides protected by tRNA) suggesting that tRNA-dependent protections of C795 and G693 are explained by a conformational change in the ribosome induced by the P-site-bound tRNA. A novel mode of pactamycin action is proposed suggesting that pactamycin restricts structural transitions in 16 S rRNA preventing the ribosome from adopting a functional conformation induced by tRNA binding.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pactamycin is a potent inhibitor of translation in all three kingdoms, eukarya, bacteria, and archaea.
“but is in fact a potent inhibitor of translation in all three kingdoms, eukarya, bacteria, and archaea (Bhuyan et al. 1961; Mankin 1997”
From The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit (2000) · cites this paper as Mankin 1997
Resistance to pactamycin is caused by either of the mutations A694G, C795U, or C796U.
“resistance to Pct has been shown to be caused by either of the mutations A694G, C795U, or C796U (Mankin 1997”
From The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit (2000) · cites this paper as Mankin 1997
Cited by
Sorted by citations
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950 · see citing works
“In addition, resistance to Pct has been shown alterations in the structure of RNA, and appears to be governed by strong base-specific hydrogen bonds to be caused by either of the mutations A694G, C795U, or C796U (Mankin, 1997).”
BackgroundInfluentialCrystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3
Pioletti, M., Schlünzen, F., Harms, J., Zarivach, R., Glühmann, M., Avila, H., Bashan, A., Bartels, H., Auerbach, T., Jacobi, C., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1829 · Cited by 527 · see citing works
Extensive natural variation in bacterial ribosomal drug-binding sites
Ekemezie, C. L., Chan, L. I., Brown, C. R., Helena-Bueno, K., Williams, T. A., & Melnikov, S. V. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115878 · Cited by 2 · see citing works
- Authors
- Mankin, A. S.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Mankin, Alexander S
- ORCID
- Mankin, Alexander S
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 274
- Issue
- 1
- Pages
- 8-15
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W1971085023
- Cited by
- 47
- References
- 0
- Citations by year
- 2025: 1 · 2024: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 3
- FWCI
- 0.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01gm053762-04)
- National Institute of General Medical Sciences (GM53762)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- 16S rRNA mutations, Halobacterium salinarum, archaea, antibiotic binding sites, ribosome conformational change, P-site tRNA, ribosomal function, protein synthesis inhibition, rRNA tertiary structure
- MeSH terms
- Base Sequence, Binding Sites, Drug Resistance, Microbial, Molecular Sequence Data, Pactamycin, RNA, Ribosomal, 16S, Mutagenesis, Site-Directed, Halobacterium salinarum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review